ASCOT-BPLA

Lancet. 2006 Jan 21;367(9506):206; author reply 207-8. doi: 10.1016/S0140-6736(06)68024-0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Amlodipine / adverse effects*
  • Amlodipine / therapeutic use
  • Calcium Channel Blockers / adverse effects*
  • Calcium Channel Blockers / therapeutic use
  • Humans
  • Hypertension / drug therapy
  • Neoplasms / chemically induced*
  • Randomized Controlled Trials as Topic

Substances

  • Calcium Channel Blockers
  • Amlodipine